Clinical trial
fMRI Study of Treatment Recommendations Comparing Recently Diagnosed Multiple…
NCT00391352 · Waukesha Memorial Hospital, Other · Completed
Key facts
| NCT number | NCT00391352 |
|---|---|
| Title | fMRI Study of Treatment Recommendations Comparing Recently Diagnosed Multiple Sclerosis (MS) Patients to Controls |
| Official title | A Phase 4, fMRI Study of Treatment Recommendations Comparing Patients Taking IFN-β-1a 44 mcg Tiw SC (Rebif®) to Controls of Patients Recently Diagnosed With Relapsing Remitting Multiple Sclerosis Currently Naive to Disease-Modifying Therapy. |
| Lead sponsor | Waukesha Memorial Hospital, Other |
| Collaborators | The Cleveland Clinic |
| Status | Completed |
| Study type | Observational |
| Conditions | Relapsing-Remitting Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | IFN-β-1a (Rebif®) |
| Enrollment | 21 |
| Start date | Feb 1, 2008 |
| Primary completion | Aug 1, 2012 |
| Completion | Aug 1, 2012 |
| First posted | Oct 23, 2006 |
| Last update posted | Jun 4, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: